Christopher Still, DO, FACN, FACP, Co-Clinical Editor, Metabolic & Bariatric Care Times; Medical Director for the Center for Nutrition and Weight Management, and Director for Geisinger Obesity Research Institute, Geisinger
John M. Morton, MD, MPH, FACS, FASMBS, Clinical Editor, Metabolic & Bariatric Care Times; Chief of the Section of Bariatric and Minimally Invasive Surgery, Stanford University, Stanford, California, and Past
Christopher Still, DO, FACN, FACP, Co-Clinical Editor, Metabolic & Bariatric Care Times; Medical Director for the Center for Nutrition and Weight Management, and Director for Geisinger Obesity Research Institute, Geisinger
John M. Morton, MD, MPH, FACS, FASMBS, Clinical Editor, Metabolic & Bariatric Care Times; Chief of the Section of Bariatric and Minimally Invasive Surgery, Stanford University, Stanford, California, and Past
Christopher Still, DO, FACN, FACP, Co-Clinical Editor, Metabolic & Bariatric Care Times; Medical Director for the Center for Nutrition and Weight Management, and Director for Geisinger Obesity Research Institute, Geisinger
Dear Friends and Readers, Welcome to the July issue of Metabolic & Bariatric Care Times. This month we are pleased to introduce a new column called “Raising the Standard,” created
Dear Colleagues, Early last month, I came across an interesting headline—”Surgery in a Pill” Developed to Mimic Benefits of Bariatric Surgery on Type 2 Diabetes.1 In this article, researchers at
A Message from Dr. John M. Morton John M. Morton, MD, MPH, FACS, FASMBS, Clinical Editor, Metabolic & Bariatric Care Times; Chief of the Section of Bariatric and Minimally Invasive
A Message from Dr. Christopher Still Christopher Still, DO, FACN, FACP, Co-Clinical Editor, Metabolic & Bariatric Care Times; Medical Director for the Center for Nutrition and Weight Management, and Director
A Message from Dr. John M. Morton John M. Morton, MD, MPH, FACS, FASMBS, Clinical Editor, Metabolic & Bariatric Care Times; Chief of the Section of Bariatric and Minimally Invasive
